FDA Drug Application (203022) for PREGABALIN by APOTEX INC

Back to FDA Applications sponsored by APOTEX INC

Application Number203022
Product Number001
FormCAPSULE;ORAL
Dosage25MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NamePREGABALIN
Active IngredientPREGABALIN

Active IngredientCount
List of drugs with Active Ingredient PREGABALIN2


Back to FDA Applications sponsored by APOTEX INC